Non-Sink Dissolution Conditions for Predicting Product Quality and In Vivo Performance of Supersaturating Drug Delivery Systems.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Pharmacy and Science

• Publication date

  2016-09-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.xphs.2016.03.024PMID 27174227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of Supersaturated Danazol Solutions – Impact of Polymers on Solution Properties and Phase Transitions

  2016cited by this paper
• Supersaturation Potential of Salt, Co-Crystal, and Amorphous Forms of a Model Weak Base

  2016cited by this paper
• Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.

  2016cited by this paper
• Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs

  2015cited by this paper
• pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs.

  2015cited by this paper
• Bile Salts as Crystallization Inhibitors of Supersaturated Solutions of Poorly Water-Soluble Compounds

  2015cited by this paper
• Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.

  2015cited by this paper
• Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.

  2015cited by this paper
• Trends in the precipitation and crystallization behavior of supersaturated aqueous solutions of poorly water-soluble drugs assessed using synchrotron radiation.

  2015cited by this paper
• Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations

  2015cited by this paper
• What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?

  2014cited by this paper
• Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs.

  2014cited by this paper
• Combining ibuprofen sodium with cellulosic polymers: a deep dive into mechanisms of prolonged supersaturation.

  2014cited by this paper
• In vitro models for the prediction of in vivo performance of oral dosage forms.

  2014cited by this paper
• Dissolution of Amorphous Solid Dispersions: Theory and Practice

  2014cited by this paper
• An improved method for the characterization of supersaturation and precipitation of poorly soluble drugs using pulsatile microdialysis (PMD).

  2014cited by this paper
• Regulatory Considerations in Development of Amorphous Solid Dispersions

  2014cited by this paper
• Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability.

  2013cited by this paper
• Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.

  2013cited by this paper
• Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.

  2013cited by this paper
• Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments

  2013cited by this paper
• Dissolution Studies of Poorly Soluble Drug Nanosuspensions in Non-sink Conditions

  2013cited by this paper
• Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir.

  2013cited by this paper
• Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction Times

  2013cited by this paper
• Liquid–Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations

  2013cited by this paper
• Technical Note: Non-Sink Dissolution Media for Identification of Functional Formulation Excipients—The Case of a Precipitation Inhibitor

  2013cited by this paper
• Nonsink In Vitro Dissolution Testing of Amorphous Solid Dispersions

  2013cited by this paper
• Characterizing the Impact of Hydroxypropylmethyl Cellulose on the Growth and Nucleation Kinetics of Felodipine from Supersaturated Solutions

  2012cited by this paper
• Modeling of diffusion controlled drug delivery.

  2012cited by this paper
• Apparent Solubility and Dissolution Profile at Non-Sink Conditions as Quality Improvement Tools

  2012cited by this paper
• Supersaturating drug delivery systems: fast is not necessarily good enough.

  2012cited by this paper
• Assessing the performance of amorphous solid dispersions.

  2012cited by this paper
• A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.

  2012cited by this paper
• Solution Behavior of PVP-VA and HPMC-AS-Based Amorphous Solid Dispersions and Their Bioavailability Implications

  2012cited by this paper
• Nucleation of organic crystals--a molecular perspective.

  2012cited by this paper
• Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.

  2012cited by this paper
• pH-Induced Precipitation Behavior of Weakly Basic Compounds: Determination of Extent and Duration of Supersaturation Using Potentiometric Titration and Correlation to Solid State Properties

  2012cited by this paper
• Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs

  2012cited by this paper
• An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine

  2012cited by this paper
• Re-evaluation of in vitro dissolution techniques for supersaturating drug delivery systems

  2012cited by this paper
• Evaluation of amorphous solid dispersion properties using thermal analysis techniques.

  2012cited by this paper
• Inhibition of solution crystal growth of ritonavir by cellulose polymers – factors influencing polymer effectiveness

  2012cited by this paper
• Physicochemical properties of the amorphous drug, cast films, and spray dried powders to predict formulation probability of success for solid dispersions: etravirine.

  2011cited by this paper
• Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion

  2011cited by this paper
• Influence of Particle Size on the Ultraviolet Spectrum of Particulate-Containing Solutions: Implications for In-Situ Concentration Monitoring Using UV/Vis Fiber-Optic Probes

  2011cited by this paper
• Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.

  2011cited by this paper
• Dissolution and precipitation behavior of amorphous solid dispersions.

  2011cited by this paper
• Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation.

  2010cited by this paper
• Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.

  2010cited by this paper
• Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.

  2010cited by this paper
• Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution

  2010cited by this paper
• Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug

  2010cited by this paper
• Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

  2009cited by this paper
• Commentary: Towards Physico-Relevant Dissolution Testing: The Importance of Solid-State Analysis in Dissolution

  2009cited by this paper
• Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug.

  2009cited by this paper
• Comprehensive validation scheme for in situ fiber optics dissolution method for pharmaceutical drug product testing.

  2009cited by this paper
• Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction.

  2008cited by this paper
• Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated.

  2008cited by this paper
• Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.

  2008cited by this paper
• Nucleation and crystal growth in supersaturated solutions of a model drug.

  2008cited by this paper
• FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms

  2008cited by this paper
• In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles.

  2007cited by this paper
• Use of Surfactants as Plasticizers in Preparing Solid Dispersions of Poorly Soluble API: Stability Testing of Selected Solid Dispersions

  2006cited by this paper
• Molecular Properties of Ibuprofen and Its Solid Dispersions with Eudragit RL100 Studied by Solid-State Nuclear Magnetic Resonance

  2005cited by this paper
• Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability.

  2005cited by this paper
• Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.

  2004cited by this paper
• Dissolution Testing Using Fiber Optics— A Regulatory Perspective

  2003cited by this paper
• Modeling and analysis of dispersed-drug release into a finite medium from sphere ensembles with a boundary layer.

  2003cited by this paper
• Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.

  2002cited by this paper
• Theoretical analyses of dispersed-drug release from planar matrices with a boundary layer in a finite medium.

  2002cited by this paper
• Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry

  2002cited by this paper
• Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by (13)C nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature.

  2001cited by this paper
• Stability of amorphous indomethacin compounded with silica.

  2001cited by this paper
• Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions.

  2001cited by this paper
• Amorphous pharmaceutical solids: preparation, characterization and stabilization.

  2001cited by this paper
• Improving drug solubility for oral delivery using solid dispersions.

  2000cited by this paper
• Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

  1999cited by this paper
• HPMC-Matrices for Controlled Drug Delivery: A New Model Combining Diffusion, Swelling, and Dissolution Mechanisms and Predicting the Release Kinetics

  1999cited by this paper
• Absorption and Scattering of Light by Small Particles

  1998cited by this paper
• Characteristics and significance of the amorphous state in pharmaceutical systems.

  1997cited by this paper
• The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro

  1997cited by this paper
• Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions

  1997cited by this paper
• Diffusional release of a dispersed solute from planar and spherical matrices into finite external volume

  1997cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations.

  1995cited by this paper
• Solubilization of mono- and dichlorophenols by hexadecylpyridinium chloride micelles. Effects of substituent groups

  1990cited by this paper
• The distribution of alkyl paraben in aqueous sodium lauryl sulfate micellar solutions

  1978cited by this paper

• Liquisolid powders of Andrographis paniculata extract: physicochemical attributes, dissolution, oral bioavailability, stability, and acute toxicity

  2026cites this paper
• Novel cocrystals of Cilostazol for enhanced solubility: screening, characterization, supramolecular assembly, and structure-property relationships

  2026cites this paper
• Intestinal Permeation Characteristics via Non-Everted Gut Sac of Diterpene Lactones from Pure Andrographolide and Three Different Andrographis Extracts: An Investigation into Liqui-Mass with Different Solvents

  2026cites this paper
• Deciphering the role of amphiphilic polymer combinations in the formation of ternary griseofulvin amorphous solid dispersions.

  2025cites this paper
• Influence of Drug Properties, Formulation Composition, and Processing Parameters on the Stability and Dissolution Performance of Amorphous Solid Dispersions-Based Tablets

  2025influential citation
• ZIF-8 as a Drug Delivery System (DDS) for Hesperidin: Synthesis, Characterization, and In Vitro Release Profile

  2025cites this paper
• Preparation and Characterization of Ternary Complexes to Improve the Solubility and Dissolution Performance of a Proteolysis-Targeting Chimera Drug

  2025cites this paper
• Design, Development, and Characterization of High Drug-Loaded Drug-Drug-Polymer Ternary Amorphous Solid Dispersions

  2025cites this paper
• Ethyl-Cellulose Nanosponges for Topical Delivery of Simvastatin with Preferential Skin Retention for Wound Healing in a Full-Thickness Wound Rat Model

  2025cites this paper
• Preparation and characterization of ASDs improves the solubility and dissolution performance of a PROTAC drug

  2025cites this paper
• Roles of Supersaturation and Liquid–Liquid Phase Separation for Enhanced Oral Absorption of Poorly Soluble Drugs from Amorphous Solid Dispersions

  2025influential citation
• Unveiling the impact of preparation methods, matrix/carrier type selection and drug loading on the supersaturation performance of amorphous solid dispersions.

  2025cites this paper
• Developing Soluplus®-Based Microparticle Amorphous Solid Dispersions with High Drug Loading for Enhanced Celecoxib Dissolution via Electrospraying

  2025influential citation
• Can an absorptive sink improve the predictivity of biomimetic two-stage dissolution testing: Comparative IVIVC of various formulations of the poorly soluble drug emodepside.

  2025cites this paper
• The Effect of Poloxamer 188 on the Solubility and Dissolution Behaviors of Piroxicam-PEG 4000 Solid Dispersions

  2025cites this paper
• Antioxidant and anticancer activities of hesperetin and its novel formulations in KB cells

  2024cites this paper
• The Impact of Volume of Dissolution Medium for Biopredictive Dissolution/Permeation Studies of Enabling Formulations: A Comparison of Two Brands of Telmisartan / Amlodipine Tablets.

  2024cites this paper
• Effect of polyoxylglycerides-based excipients (Gelucire®) on ketoprofen amorphous solubility and crystallization from the supersaturated state.

  2024cites this paper
• Impact of sink conditions on drug release behavior of controlled-release formulations.

  2024cites this paper
• Professor Lynne Taylor: Scientist, Educator, and Adventurer.

  2024cites this paper
• Amorphous Solubility Advantage: Theoretical Considerations, Experimental Methods, and Contemporary Relevance.

  2024cites this paper
• Assessing Structures and Solution Behaviors of Molecular and Ionic Cocrystals with a Common Bioactive Molecule: 2,4-Pyridinedicarboxylic Acid with Tranexamic Acid and Nicotinamide

  2024cites this paper
• 6-Carboxycellulose Acetate Butyrate: Effectiveness as an Amorphous Solid Dispersion Polymer.

  2024cites this paper
• Quantification of Soluplus for Dissolution Tests: SEC Method Development and Validation.

  2024cites this paper
• Optimizing Nonsink Dissolution Testing for Amorphous Solid Dispersions: Exploring Sample Handling Variables.

  2024cites this paper
• Estimation of the concentration boundary layer adjacent to a flat surface using computational fluid dynamics.

  2024cites this paper
• The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability

  2024influential citation
• Development and characterization of co-amorphous griseofulvin/L-leucin by modified solvent processing hot-melt extrusion.

  2024cites this paper
• Drug-Coformer Loaded-Mesoporous Silica Nanoparticles: A Review of the Preparation, Characterization, and Mechanism of Drug Release

  2024cites this paper
• Design development and optimisation of multifunctional Doxorubicin-loaded Indocynanine Green proniosomal gel derived niosomes for tumour management

  2023cites this paper
• Praziquantel Fifty Years on: A Comprehensive Overview of Its Solid State

  2023influential citation
• Naringin processing using GAS antisolvent technique and in vivo applications

  2023cites this paper
• 高速攪拌造粒機を用いた乾式レイヤリング造粒法の開発と非晶質製剤設計への応用

  2023cites this paper
• Overcoming drug impurity challenges in amorphous solid dispersion with rational development of biorelevant dissolution-permeation method.

  2023cites this paper
• Amorphous solid dispersions: Stability mechanism, design strategy and key production technique of hot melt extrusion.

  2023cites this paper
• Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?

  2023cites this paper
• Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions.

  2023cites this paper
• Comparative analysis of drug-salt-polymer interactions by experiment and molecular simulation improves biopharmaceutical performance

  2023cites this paper
• VIRTUAL BIOEQUIVALENCE IN PHARMACEUTICALS: CURRENT STATUS AND FUTURE PROSPECTS

  2023cites this paper
• Polymeric amorphous dispersion as a carrier to enhance the in vitro dissolution in vivo pharmacokinetics and cytotoxicity of niclosamide

  2023cites this paper
• Tailoring the release of drugs having different water solubility by hybrid polymer-lipid microparticles with a biphasic structure.

  2023cites this paper
• Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer

  2023cites this paper
• Development, recent advances, and updates in binary, ternary co-amorphous systems, and ternary solid dispersions

  2023cites this paper
• Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing.

  2023cites this paper
• Assessing the performance of thermally crosslinked amorphous solid dispersions with high drug loadings.

  2023cites this paper
• Effect of Different Seed Crystals on the Supersaturation State of Ritonavir Tablets Prepared by Hot-Melt Extrusion.

  2023cites this paper
• Effect of Molecular Weight on the Dissolution Profiles of PEG Solid Dispersions Containing Ketoprofen

  2023cites this paper
• Orodispersible film incorporating nanoparticulate loratadine for an enhanced oral bioavailability

  2023cites this paper
• Solventless amorphization and pelletization using a high shear granulator. Part II; preparation of co-amorphous mixture-layered pellets using indomethacin and arginine.

  2022cites this paper
• Impact of Bile Salt on Solution-Mediated Phase Transformation of Pharmaceutical Cocrystals: The Importance of Coformer Release Kinetics

  2022cites this paper
• In silico–assisted development of supersaturable preconcentrated isotropic mixture of atazanavir for augmenting biopharmaceutical performance in the presence of H2-receptor antagonist

  2022cites this paper
• EUTECTIC MIXTURE AND AMORPHOUS SOLID DISPERSION: TWO DIFFFERENT STRATEGIES FOR SUPERSATURATING DRUG DELIVERY SYSTEMS TO IMPROVE GRISEOFULVIN RELEASE USING SACCHARIN.

  2022cites this paper
• Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and In Vivo Oral Absorption.

  2022cites this paper
• Poly (Lactic-Co-Glycolic) Acid–Poly (Vinyl Pyrrolidone) Hybrid Nanoparticles to Improve the Efficiency of Oral Delivery of β-Carotene

  2022cites this paper
• Validation of UV spectrophotometric method for ketoprofen multicomponent crystals with malic acid and tartaric acid

  2022cites this paper
• Formulation and processing strategies which underpin susceptibility to matrix crystallization in amorphous solid dispersions.

  2022cites this paper
• Design and Evaluation of Two-Step Biorelevant Dissolution Methods for Docetaxel Oral Formulations

  2022cites this paper
• Thinking of bosentan repurposing - A study on dehydration and amorphization.

  2022cites this paper
• Polymer selection to increase in vitro supersaturation generated by lamotrigine nicotinamide monohydrate cocrystal: An evaluation with predissolved and solid polymers

  2022cites this paper
• Applications of bio-predictive dissolution tools for the development of solid oral dosage forms: current industry experience

  2022cites this paper
• Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.

  2022cites this paper
• Structural, Physicochemical, and Biopharmaceutical Properties of Cocrystals with RS- and R-Praziquantel─Generation and Prolongation of the Supersaturation State in the Presence of Cellulosic Polymers

  2022cites this paper
• An Artificial Gut/Absorption Simulator: Simultaneous Evaluation of Desupersaturation and Absorption from Ketoconazole Supersaturated Solutions.

  2022cites this paper
• Impact of Aluminum Oxide Nanocoating on Drug Release from Amorphous Solid Dispersion Particles.

  2022cites this paper
• Challenges and Strategies for Solubility Measurements and Dissolution Method Development for Amorphous Solid Dispersion Formulations

  2022cites this paper
• Development And Optimisation Of Magnesium Alumino Metasilicate Loaded Tacrolimus Extended Release Tablets By Qbd Approach For Management Of Oragan Transplantation

  2022cites this paper
• Biorelevant Dissolution Method Considerations for the Appropriate Evaluation of Amorphous Solid Dispersions: are Two Stages Necessary?

  2022cites this paper
• Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer Cells

  2021cites this paper
• Crystal engineering of valproic acid and carbamazepine to improve hygroscopicity and dissolution profile

  2021cites this paper
• Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.

  2021cites this paper
• Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19

  2021cites this paper
• Enhanced Supersaturation via Fusion-Assisted Amorphization during FDM 3D Printing of Crystalline Poorly Soluble Drug Loaded Filaments

  2021cites this paper
• Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals

  2021cites this paper
• Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical Technologies in Drug Product Development

  2021cites this paper
• Predicting in vivo performance of fenofibrate amorphous solid dispersions using in vitro non-sink dissolution and dissolution permeation setup.

  2021cites this paper
• Role of Permeability on the Biopredictive Dissolution of Amorphous Solid Dispersions

  2021cites this paper
• ArticleAmorphous Solid Dispersions (ASDs): The influence of material properties

  2021cites this paper
• Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity

  2021influential citation
• HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm

  2021cites this paper
• Laser diffraction as a powerful tool for amorphous solid dispersion screening and dissolution understanding.

  2021cites this paper
• Impact of Laser Speed and Drug Particle Size on Selective Laser Sintering 3D Printing of Amorphous Solid Dispersions

  2021cites this paper
• Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol.

  2021cites this paper
• Recent Advances in Dissolution Testing and Their Use to Improve In Vitro–In Vivo Correlations in Oral Drug Formulations

  2021cites this paper
• On the usefulness of sink index in characterizing the degree of nonsinkness in dissolution studies.

  2021cites this paper
• Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization

  2021cites this paper
• Impact of Structural Binding Energies on Dissolution Rates for Single Faceted-Crystals

  2021cites this paper
• Enabling modular dosage form concepts for individualized multidrug therapy: expanding the design window for poorly water-soluble drugs.

  2021cites this paper
• Dose-Dependent Solubility–Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions

  2021cites this paper
• A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions

  2021cites this paper
• A novel amorphous solid dispersion based on drug–polymer complexation

  2020cites this paper
• Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation

  2020cites this paper
• An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design.

  2020cites this paper
• Novel analytical approaches for solid dispersion characterization

  2020cites this paper
• Comparison of Downstream Processing of Nanocrystalline Solid Dispersion and Nanosuspension of Diclofenac Acid to Develop Solid Oral Dosage Form

  2020cites this paper
• The isonicotinamide cocrystal promotes inhibitory effects of naringenin on nonalcoholic fatty liver disease in mice

  2020cites this paper
• Similarity of dissolution profiles from biorelevant media: Assessment of interday repeatability, interanalyst repeatability, and interlaboratory reproducibility using ibuprofen and ketoconazole tablets.

  2020cites this paper
• Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update

  2020cites this paper
• The tangential flow absorption model (TFAM) - a novel dissolution method for evaluating the performance of amorphous solid dispersions of poorly water-soluble actives.

  2020cites this paper
• In situ supersaturable polyhydrogels: A feasible modification of the conventional hydrogels for the enhanced delivery of stomach specific hydrophobic drugs

  2020cites this paper
• In vitro and in vivo behavior of KinetiSol® and spray dried amorphous solid dispersions of a weakly basic drug and ionic polymer.

  2020cites this paper